These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 10933051

  • 1. Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.
    Chahlavi A, Todo T, Martuza RL, Rabkin SD.
    Neoplasia; 1999 Jun; 1(2):162-9. PubMed ID: 10933051
    [Abstract] [Full Text] [Related]

  • 2. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.
    Kim SH, Wong RJ, Kooby DA, Carew JF, Adusumilli PS, Patel SG, Shah JP, Fong Y.
    Eur J Cancer; 2005 Jan; 41(2):313-22. PubMed ID: 15661558
    [Abstract] [Full Text] [Related]

  • 3. Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207).
    Carew JF, Kooby DA, Halterman MW, Federoff HJ, Fong Y.
    Hum Gene Ther; 1999 Jul 01; 10(10):1599-606. PubMed ID: 10428205
    [Abstract] [Full Text] [Related]

  • 4. Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma.
    Cinatl J, Cinatl J, Michaelis M, Kabickova H, Kotchetkov R, Vogel JU, Doerr HW, Klingebiel T, Driever PH.
    Cancer Res; 2003 Apr 01; 63(7):1508-14. PubMed ID: 12670897
    [Abstract] [Full Text] [Related]

  • 5. Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma.
    Jiang M, Liu Z, Xiang Y, Ma H, Liu S, Liu Y, Zheng D.
    BMC Cancer; 2011 Feb 03; 11():54. PubMed ID: 21291526
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxic effects of the oncolytic herpes simplex virus HSV1716 alone and in combination with cisplatin in head and neck squamous cell carcinoma.
    Mace AT, Harrow SJ, Ganly I, Brown SM.
    Acta Otolaryngol; 2007 Aug 03; 127(8):880-7. PubMed ID: 17763002
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters.
    Nakano K, Todo T, Chijiiwa K, Tanaka M.
    Mol Ther; 2001 Apr 03; 3(4):431-7. PubMed ID: 11319903
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.
    Lin SF, Gao SP, Price DL, Li S, Chou TC, Singh P, Huang YY, Fong Y, Wong RJ.
    Clin Cancer Res; 2008 Mar 01; 14(5):1519-28. PubMed ID: 18316577
    [Abstract] [Full Text] [Related]

  • 10. Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus.
    Wong RJ, Kim SH, Joe JK, Shah JP, Johnson PA, Fong Y.
    J Am Coll Surg; 2001 Jul 01; 193(1):12-21. PubMed ID: 11442249
    [Abstract] [Full Text] [Related]

  • 11. Cisplatin enhances the efficacy of 5-aminolevulinic acid mediated photodynamic therapy in human head and neck squamous cell carcinoma.
    Ahn JC, Biswas R, Mondal A, Lee YK, Chung PS.
    Gen Physiol Biophys; 2014 Jul 01; 33(1):53-62. PubMed ID: 23846261
    [Abstract] [Full Text] [Related]

  • 12. Treatment of human renal cell carcinoma by a conditionally replicating herpes vector G207.
    Oyama M, Ohigashi T, Hoshi M, Murai M, Uyemura K, Yazaki T.
    J Urol; 2001 Apr 01; 165(4):1274-8. PubMed ID: 11257700
    [Abstract] [Full Text] [Related]

  • 13. Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination models.
    Nakano K, Todo T, Zhao G, Yamaguchi K, Kuroki S, Cohen JB, Glorioso JC, Tanaka M.
    J Gene Med; 2005 May 01; 7(5):638-48. PubMed ID: 15754306
    [Abstract] [Full Text] [Related]

  • 14. A novel approach to cancer therapy using an oncolytic herpes virus to package amplicons containing cytokine genes.
    Carew JF, Kooby DA, Halterman MW, Kim SH, Federoff HJ, Fong Y.
    Mol Ther; 2001 Sep 01; 4(3):250-6. PubMed ID: 11545616
    [Abstract] [Full Text] [Related]

  • 15. Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy.
    Todo T, Rabkin SD, Chahlavi A, Martuza RL.
    Hum Gene Ther; 1999 Nov 20; 10(17):2869-78. PubMed ID: 10584932
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors.
    Todo T, Rabkin SD, Martuza RL.
    Cancer Gene Ther; 2000 Jun 20; 7(6):939-46. PubMed ID: 10880026
    [Abstract] [Full Text] [Related]

  • 17. Tumor reduction in vivo after adenoviral mediated gene transfer of the herpes simplex virus thymidine kinase gene and ganciclovir treatment in human head and neck squamous cell carcinoma.
    Goebel EA, Davidson BL, Graham SM, Kern JA.
    Otolaryngol Head Neck Surg; 1998 Oct 20; 119(4):331-6. PubMed ID: 9781985
    [Abstract] [Full Text] [Related]

  • 18. Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer.
    Zager JS, Delman KA, Malhotra S, Ebright MI, Bennett JJ, Kates T, Halterman M, Federoff H, Fong Y.
    Mol Med; 2001 Aug 20; 7(8):561-8. PubMed ID: 11591892
    [Abstract] [Full Text] [Related]

  • 19. Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation.
    McNally LR, Rosenthal EL, Zhang W, Buchsbaum DJ.
    Cancer Gene Ther; 2009 Mar 20; 16(3):246-55. PubMed ID: 18846112
    [Abstract] [Full Text] [Related]

  • 20. Antitumor effects of telomelysin in combination with paclitaxel or cisplatin on head and neck squamous cell carcinoma.
    Kondo N, Tsukuda M, Kimura M, Fujita K, Sakakibara A, Takahashi H, Ishiguro Y, Toth G, Matsuda H.
    Oncol Rep; 2010 Feb 20; 23(2):355-63. PubMed ID: 20043095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.